Spesolimab: all 32 studies that test it

Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.

• A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma GangrenosumRecruitingNCT06624670Phase 3
• A Study to Test Long-term Treatment With Spesolimab in People With a Skin Condition Disease Called Hidradenitis Suppurativa (HS) Who Took Part in a Previous Study With SpesolimabTerminatedNCT06241573Phase 2/3Results posted
• Spesolimab in Pyoderma GangrenosumTerminatedNCT06092216Phase 2Results posted
• A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Netherton SyndromeTerminatedNCT05856526Phase 2/3Results posted
• Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis SuppurativaCompletedNCT05819398Phase 2/3Results posted
• An Expanded Access Program in China to Provide Spesolimab to People With a Flare-up in Generalized Pustular Psoriasis Who Have no Other Treatment OptionsCompletedNCT05239039Phase 3Results posted
• An Expanded Access Trial in Japan to Provide Spesolimab to People With a Flare-up in Generalized Pustular Psoriasis Who Have no Other Treatment OptionsCompletedNCT05200247Phase 3Results posted
• A Study to Test Whether Spesolimab Helps People With Crohn's Disease Who Have Symptoms of Bowel ObstructionTerminatedNCT05013385Phase 2Results posted
• A Study Investigating Long-term Treatment With Spesolimab in People With a Skin Disease Called Hidradenitis Suppurativa Who Completed a Previous Clinical TrialCompletedNCT04876391Phase 2Results posted
• A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis SuppurativaCompletedNCT04762277Phase 2Results posted
• A Study to Test Long-term Treatment With Spesolimab in People With Palmoplantar Pustulosis (PPP) Who Took Part in Previous Studies With SpesolimabTerminatedNCT04493424Phase 2Results posted
• A Study to Test Whether BI 655130 (Spesolimab) Prevents Flare-ups in Patients With Generalized Pustular PsoriasisCompletedNCT04399837Phase 2Results posted
• A Trial in Healthy Chinese Volunteers to Test How Different Doses of BI 655130 Are Taken up in the BodyCompletedNCT04390568Phase 1Results posted
• A Study to Test Long-term Treatment With Spesolimab in Patients With Fistulising Crohn's Disease Who Took Part in Previous TrialsTerminatedNCT04362254Phase 2Results posted
• A Study to Test the Long-term Safety of BI 655130 in Patients With Atopic Eczema Who Took Part in Study 1368-0032TerminatedNCT04086121Phase 2Results posted
• A Study to Test How Effective and Safe Different Doses of BI 655130 Are in Patients With a Moderate to Severe Form of the Skin Disease Palmoplantar PustulosisCompletedNCT04015518Phase 2Results posted
• A Study in Patients With Atopic Eczema to Test How Effective BI 655130 is and How Well it is ToleratedCompletedNCT03822832Phase 2Results posted
• Effisayil™ 1: A Study to Test Spesolimab (BI 655130) in Patients With a Flare-up of a Skin Disease Called Generalized Pustular PsoriasisCompletedNCT03782792Phase 2Results posted
• A Study Testing How BI 655130 Works in Patients With Fistulizing Crohn's DiseaseCompletedNCT03752970Phase 2Results posted
• BI 655130 Long-term Treatment in Patients With moderate-to Severe Ulcerative ColitisCompletedNCT03648541Phase 2Results posted
• BI655130 (SPESOLIMAB) Induction Treatment in Patients With Moderate-to-severe Ulcerative ColitisCompletedNCT03482635Phase 2/3Results posted
• Initial Dosing of BI 655130 in Palmoplantar Pustulosis PatientsCompletedNCT03135548Phase 2Results posted
• A Study in Patients With Mild or Moderate Ulcerative Colitis Who Take a TNF Inhibitor. The Study Investigates Whether Bowel Inflammation Improves When Patients Take BI 655130 in Addition to Their Current TherapyCompletedNCT03123120Phase 2Results posted
• Single Rising Dose Trial of Spesolimab (BI 655130) for Healthy Japanese Male SubjectsCompletedNCT03123094Phase 1Results posted
• Safety, Tolerability, and Pharmacokinetics of a Subcutaneous and Intravenous Dose of BI 655130 in Healthy SubjectsCompletedNCT03100903Phase 1Results posted
• This Study Tests How BI 655130 Works in Patients With Active Ulcerative Colitis. The Study Also Tests How Well BI 655130 is Tolerated and Whether it Helps the PatientsCompletedNCT03100864Phase 2Results posted
• Spesolimab (BI 655130) Single Dose in Generalized Pustular PsoriasisCompletedNCT02978690Phase 1Results posted
• Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 655130 in Healthy Male VolunteersCompletedNCT02852824Phase 1Results posted
• Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 655130 in Healthy Male VolunteersCompletedNCT02525679Phase 1Results posted
• A Study to Test How Well Healthy People Tolerate Spesolimab When Given in 2 Different WaysCompletedNCT06520514Phase 1
• A Study to Test Whether Spesolimab Helps People With Generalized Pustular Psoriasis (GPP) Who Need Treatment for Repeated FlaresCompletedNCT06013969Phase 4
• Effisayil™ ON: A Study to Test Long-term Treatment With Spesolimab in People With Generalized Pustular Psoriasis Who Took Part in a Previous StudyActive, not recruitingNCT03886246Phase 2

← Spesolimab overview